Boehringer Ingelheim Collaborates with Sosei Heptares for Antipsychotic Drugs

By Amit Kaushik

Pharma Deals Review: Vol 2024 Issue 3 (Table of Contents)

Published: 27 Mar-2024

DOI: 10.3833/pdr.v2024.i3.2866     ISSN: 1756-7874

Section: Research & Development



In an attempt to diversify its pipeline, Boehringer Ingelheim has signed a strategic collaboration and licensing agreement, worth up to €755 M (US$825...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details